الحاوی
دحاوی | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 7,210 3.00
Close Price: 7,210
Income Statement
AGM
Interim
2026/07/22 Fiscal Year 2026/03/2012 Month | 2025/07/02 Fiscal Year 2025/03/2012 Month | 2024/09/19 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 18.499 Trillion | 8.847 Trillion | 10.879 Trillion | |
Total Revenues | 18.499 Trillion | 8.847 Trillion | 10.879 Trillion | |
Cost of Goods Sold | 11.841 Trillion | 6.472 Trillion | 6.162 Trillion | |
Gross Profit | 6.658 Trillion | 2.375 Trillion | 4.717 Trillion | |
General & Administrative Expenses | 2.409 Trillion | 1.42 Trillion | 1.589 Trillion | |
Net Operating Income & Expenses | 342.615 Billion | 172.311 Billion | 156.412 Billion | |
Operating Profit (Loss) | 4.591 Trillion | 1.127 Trillion | 3.285 Trillion | |
Profit Before Tax | 4.439 Trillion | 944.298 Billion | 753.947 Billion | |
Tax | 1.099 Trillion | 232.791 Billion | 186.41 Billion | |
Net Profit (Loss) After Tax | 3.34 Trillion | 646.153 Billion | 533.907 Billion | |
Retained Earnings at Beginning of Period | 3.659 Trillion | 3.304 Trillion | 3.678 Trillion | |
Prior-Year Adjustments | -673.34 Billion | - | - | |
Prior-Year Tax | - | 65.354 Billion | 33.63 Billion | |
Approved Dividends — Prior Year AGM | -64.8 Billion | -259.2 Billion | -216 Billion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | - | - | -665.025 Billion | |
Allocable Profit | 6.26 Trillion | 3.691 Trillion | 3.331 Trillion | |
Legal Reserve | 166.996 Billion | 32.307 Billion | 26.695 Billion | |
Approved Dividends — Current Year | 1.62 Trillion | 64.8 Billion | 259.2 Billion | |
Retained Earnings at End of Period | 4.473 Trillion | 3.594 Trillion | 3.045 Trillion |